FDA approves SinoT’s ANDA application for Mesalamine, delayed-release tablets

    Mesalamine, delayed-release tablets is an aminosalicylate indicated for the:1) induction and maintenance of remission in adult patients with mildly to moderately active ulcerative colitis. 2) treatment of mildly to moderately active ulcerative colitis in pediatric patients weighing at least 24 kg.


    SinoT is a specialty pharma with focus on the research & development, commercialization and sale of complex generics and 505(b2) products. We dedicated to developing high quality medicines that meet with international standards. We’ll do more than our best to benefit the patients in the future.

Shanghai Head Office

Greenland Being Fun Plaza, Bldg. 1, Rm. 207, Pudong New District, Shanghai

Manufacturing Site inJiangsu

No. 163 Zhuhai Road, Haimen Area, Nantong City, Jiangsu Province

Copyright © 2014-2022 SINOTHERAPEUTICS.COM ICP:13048014-1   Powered by Yongsy

Privacy Legal